Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Bookrunner on Nikola Corporation’s USD 275m Combined Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Otovo’s NOK 450 million Follow-on Offering Bryan, Garnier & Co acts as European Lead Manager on Abivax’s USD 236 million Nasdaq IPO Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Egetis Therapeutics on a Combined Offering of SEK 462m Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Median Technologies’ EUR 21.6 million Follow-On Offering & Convertible Bonds Issuance Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Carbios’ EUR 141m Rights Issue Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on HydrogenPro’s NOK 126 million Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Medincell’s EUR 25 million Follow-on Offering Bryan, Garnier & Co acts as Financial Advisor & Placement Agent on Abivax’s EUR 130 million Cross-over Financing Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on a €20m secondary offering of HRS shares Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ Nasdaq Stockholm SEK 210 million Follow-on Offering
